ArticleFrontiers in oncology2026

Consolidation cycles, measurable residual disease, and DNMT3A/ASXL1 mutations independently predict relapse-free survival in older adults with acute myeloid leukemia.

Xiaolan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.